Figure 4.
Figure 4. Single-patient hematologic data for 2 patients treated with tandutinib. The patients received (A) tandutinib 525 mg twice daily or (B) tandutinib 700 mg twice daily. WBCs indicate, white blood cells; ANC, absolute neutrophil count; APB, absolute peripheral blasts.

Single-patient hematologic data for 2 patients treated with tandutinib. The patients received (A) tandutinib 525 mg twice daily or (B) tandutinib 700 mg twice daily. WBCs indicate, white blood cells; ANC, absolute neutrophil count; APB, absolute peripheral blasts.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal